Regulatory issues on pharmacovigilance in Latin American countries
Loading...
Files
External sources
External sources
Date
Advisor
Coadvisor
Graduate program
Undergraduate course
Journal Title
Journal ISSN
Volume Title
Publisher
Network of Centres for Study of Pharmaceutical Law
Type
Article
Access right
Acesso restrito
Files
External sources
External sources
Abstract
Pharmacovigilance is responsible for monitoring the safety of medicines in normal clinical use andduring clinical trials. Legal requirements for pharmacovigilance in some Latin American countries (Argentina, Brazil, Chile, Paraguay and Uruguay) were reviewed. Disparities in the legal framework among the countries are observed being those for marketing authorization holders one of the most evident. Theactive rol of the universities and drug information centers for/of pharmacovilance seems to be a positivecommon point. Legal requirements regarding pharmacovigilance of biosimilar medicines, is still a pointto be developed.
Description
Keywords
Drug information services, Product surveillance, Postmarketing, Pharmaceutical industry, Pub-lic health
Language
English
Citation
Pharmaceuticals Policy and Law, v. 16, p. 289-312, 2014.
